Impact of Previous Exposure to Macrolide Antibiotics on Helicobacter pylori Infection Treatment Outcomes

Helicobacter Pylori

Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study

Helicobacter

Gunaratne AW, Hamblin H, Clancy A, Magat AJMC, Dawson MVM, Tu J, Borody TJ

doi: 10.1111/hel.12830

Helicobacter Pylori

Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota

J Gastroenterol Hepatol.

Liou JM, Lee YC, Wu MS

doi: 10.1111/jgh.14992.

Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains

Aliment Pharmacol Ther.

Gatta L, Scarpignato C, Fiorini G, Belsey J, Saracino IM, Ricci C, Vaira D

doi: 10.1111/apt.14597.

Helicobacter Pylori

Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection

Am J Gastroenterol.

Kumar S, Metz DC, Kaplan DE, Goldberg DS

doi: 10.14309/ajg.0000000000000626.

Helicobacter Pylori

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial

Lancet Infect Dis.

Liou JM, Chen CC, Chang CM, Fang YJ, Bair MJ, Chen PY, Chang CY, Hsu YC, Chen MJ, Chen CC, Lee JY, Yang TH, Luo JC, Chen CY, Hsu WF, Chen YN, Wu JY, Lin JT, Lu TP, Chuang EY, El-Omar EM, Wu MS, Taiwan Gastrointestinal Disease and Helicobacter Consortium.

doi: 10.1016/S1473-3099(19)30272-5.

Helicobacter Pylori

Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies

Helicobacter.

Ciccaglione AF, Cellini L, Marzio L

doi: 10.1111/hel.12606.

Helicobacter Pylori

Protocol of the European Registry on the management of Helicobacter pylori infection (Hp-EuReg)

Helicobacter.

McNicholl AG, O'Morain CA, Megraud F, Gisbert JP, As Scientific Committee of the Hp-Eureg on Behalf of the National Coordinators.

doi: 10.1111/hel.12630.

RECOMMENDED

Helicobacter Pylori

Review: Treatment of Helicobacter pylori Infection 2019

Helicobacter.

O'Connor A, Liou JM, Gisbert JP, O'Morain C

doi: 10.1111/hel.12640.

Gastritis

Th-17 response and antimicrobial peptide expression are uniformly expressed in gastric mucosa of Helicobacter pylori-infected patients independently of their clinical outcomes

Helicobacter.

Cremniter J, Bodet C, Tougeron D, Dray X, Guilhot J, Jégou JF, Morel F, Lecron JC, Silvain C, Burucoa C

doi: 10.1111/hel.12479.

Related content

Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study

Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota

Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains

Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial

Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies

Protocol of the European Registry on the management of Helicobacter pylori infection (Hp-EuReg)

Review: Treatment of Helicobacter pylori Infection 2019

Th-17 response and antimicrobial peptide expression are uniformly expressed in gastric mucosa of Helicobacter pylori-infected patients independently of their clinical outcomes